Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors

Dec. 7, 2020

Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs

Dec. 7, 2020

New MAPK 1 inhibitors identified at Medshine Discovery

Dec. 7, 2020

Phase III study of masitinib in first-line pancreatic cancer with pain shows survival increase

Dec. 4, 2020

Henan Zhiwei Biomedicine, Henan Normal University present new BTK inhibitors

Dec. 4, 2020

New EGFR inhibitors discovered at Zhejiang University

Dec. 4, 2020

Sirnaomics to start phase I trial of STP-705 in liver cancer

Dec. 4, 2020

Telix cleared to begin first-in-human study of TLX-592 for prostate cancer

Dec. 4, 2020

Phase III ATLANTIS results with Zepzelca and doxorubicin for SCLC

Dec. 3, 2020

New inhibitors of autophagy identified at Deciphera Pharmaceuticals

Dec. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...